Nephrogenic systemic fibrosis: A case series suggesting gadolinium as a possible aetiological factor

British Journal of Dermatology

Volumn 157, Issue 4, 2007, Pages 783-787

  Moreno Romero, J A ^a   Segura, S ^a   Mascaro Jr J M ^a   Cowper, S E ^b   Julia M ^a   Poch, E ^a   Botey, A ^a   Herrero, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gadolinium; Nephrogenic fibrosing dermopathy; Nephrogenic systemic fibrosis

Indexed keywords

ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 13A; C REACTIVE PROTEIN; CD34 ANTIGEN; CENTROMERE ANTIBODY; CHLORDANE; COLLAGEN; CREATININE; CYCLOPHOSPHAMIDE; GADOLINIUM; HEMOGLOBIN; MUCIN; PREDNISONE; PROCOLLAGEN; SCL 70 ANTIBODY;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ANAMNESIS; ANEMIA; ARTICLE; CARDIOPULMONARY ARREST; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART TAMPONADE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERKALEMIA; KIDNEY ARTERY STENOSIS; KIDNEY FIBROSIS; LABORATORY TEST; LEUKOCYTOSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; METABOLIC ACIDOSIS; MICROSTOMIA; NEUTROPHILIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SKIN DISEASE; TREATMENT OUTCOME; URETER DILATATION;

ADULT; AGED; CONTRAST MEDIA; DRUG ERUPTIONS; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; HYPERPIGMENTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; SKIN;

EID: 34548583578     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08067.x     Document Type: Article

References (20)

1. Cowper SE, Su L, Bhawan J et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001 23 : 383 93.
2. Cowper SE, Robin HS, Steinberg SM et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000 356 : 1000 1.
3. The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR). Available at: http://www.icnfdr.org (last accessed 2 April 2007).
4. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006 21 : 1104 8.
5. Mackay-Wiggan JM, Cohen DJ, Hardy MA et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003 48 : 55 60.
6. Mendoza FA, Artlett CM, Sandorfi N et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 2006 35 : 238 49.
7. Quan TE, Cowper SE, Wu SP et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004 36 : 598 606.
8. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 2003 25 : 358.
9. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003 139 : 903 6.
10. Jimenez SA, Arlett CM, Sandorfi N et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Arthritis Rheum 2004 50 : 2660 6.
11. Levine JM, Taylor RA, Elman LB et al. Involvement of skeletal muscle in dialysis-associated fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 2004 30 : 569 77.
12. Hershko K, Hull C, Ettefagh L et al. A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodelling? J Cutan Pathol 2004 31 : 262 5.
13. Chiu H, Wells G, Carag H et al. Nephrogenic fibrosing dermopathy: a rare entity in patients awaiting liver transplantation. Liver Transpl 2004 10 : 465 6.
14. Swartz RD, Crofford LJ, Phan SH et al. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003 114 : 563 72.
15. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003 15 : 785 90.
16. Cowper SE, Bucala R, Leboit PE. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis - setting the record straight. Semin Arthritis Rheum 2006 35 : 208 10.
17. Fabrizi F, Sangiorgio R, Pontoriero G et al. Antiphospholipid (aPL) antibodies in end-stage renal disease. J Nephrol 1999 12 : 89 94.
18. Swaminathan S, Ahmed I, McCarthy J et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 2006 145 : 234 5.
19. U.S. Food and Drug Administration. Public Health Advisory. Gadolinium-Containing Contrast Agents for Magnetic Resonance Imaging. Available at: http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm (last accessed 2 April 2007).
20. Okada S, Katagiri K, Kumazaki T, Yokohama H. Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol 2001 42 : 339 41.